Delivery Order SPE2DB22D1041-SPE2DB24FUBH8

Award Date 5/8/24
Potential Completion Date 5/9/24
Potential Value $14K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,366.13 firm fixed-price delivery order is for the supply of 4,563,851,552 units of Bupropion HCL XL 150 mg tablets. The contract has an ultimate completion date of March 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,239.60, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Bupropion HCL XL 90-count tablets. The award is not associated with any set-aside designation, and Amerisourcebergen was selected on a full and open competition basis. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was made by the Defense Logistics Agency (DLA) for the delivery of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $5,857.30 and runs through May 6, 2024. This contract is not designated as a set-aside award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $38,618.22 firm fixed-price delivery order is for the supply of 500 units of Bupropion HCl XL 300 mg tablets, which are used to treat mental health conditions. The award has an ultimate completion date of February 12, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,468.64 and is a Firm Fixed Price Delivery Order that runs through February 28, 2024. The contract was awarded on February 27, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Bupropion HCL XL 300 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The contract has a ceiling value of $9,298.78 and a period of performance through February 2024. The contract was awarded on a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $57,461.12 for the supply of Bupropion HCL XL 150 mg tablets to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022 through full and open competition, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $63,780.64, for the supply of 4564416340 - Bupropion HCL XL 300 MG Tablets in quantities of 500s. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.92, is a firm fixed-price delivery order for the supply of 4565058004 - Bupropion HCL XL 300 mg Tablets in 500 count bottles. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,384.18 Firm Fixed Price Delivery Order contract is for the provision of 4567363926 - BUPROPION HCL XL 300 MG TABLET 500S. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUBH8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,543,508 units of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $13,933.62 and is a firm fixed-price delivery order that will run through May 9, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 8/7/24, 10:31 AM